Shanghai RAAS Blood Products Co., Ltd.
002252
Rangering i aksjer
#3548
Shanghai RAAS Blood Products Co., Ltd. engages in the research, development,... Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. It provides human albumin, intravenous injection of human immunoglobulin, coagulation factor products, vaccines, diagnostic reagents, and testing services. The company was founded by Kieu Hoang on October 29, 1988 and is headquartered in Shanghai, China.
Aksjekurs
$0.7157778
Markedsverdi
$4.72B
Endring (1 dag)
-1.44%
Endring (1 år)
-23.98%
Land
CN
Handel Shanghai RAAS Blood Products Co., Ltd. (002252)
Kategori
Healthcare
Aksjeprishistorikk for Shanghai RAAS Blood Products Co., Ltd. (002252)
Høyeste sluttskurs: $0.72 den 2026-10-01
Laveste sluttskurs: $0.31 den 2008-06-01
Laveste sluttskurs: $0.31 den 2008-06-01
Aksjeprishistorikk for Shanghai RAAS Blood Products Co., Ltd. fra 2008 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2026 (TTM) | -10.94% |
| 2025 | -9.89% |
| 2024 | -10.82% |
| 2023 | 37.89% |
| 2022 | -19.09% |
| 2021 | -14.15% |
| 2020 | 14.88% |
| 2019 | -39.74% |
| 2018 | -42.57% |
| 2017 | -5.12% |
| 2016 | -8.73% |
| 2015 | 68.38% |
| 2014 | 1.42% |
| 2013 | 244.29% |
| 2012 | 1.81% |
| 2011 | -31.43% |
| 2010 | 83.78% |
| 2009 | 43.19% |
| 2008 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $535.90 | 25.67% |
US
|
|
| $184.77 | 588.14% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $881.33 | 8.25% |
NL
|
